Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/6560
DC FieldValueLanguage
dc.contributor.authorBOCCI, VELIOen_us
dc.contributor.authorZanardi, Iacopoen_us
dc.contributor.authorVALACCHI, GIUSEPPEen_us
dc.contributor.authorBORRELLI, EMMAen_us
dc.contributor.authorTravagli, Valteren_us
dc.date.accessioned2021-03-30T16:04:11Z-
dc.date.available2021-03-30T16:04:11Z-
dc.date.issued2015-
dc.identifier.issn1871-529Xen_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/6560-
dc.description205746en_US
dc.description.abstractThe state-of-the-art of oxygen-ozone therapy is now clarified and all the mechanisms of action of medical ozone are within classical biochemistry and molecular biology. The outcomes of standard treatments in peripheral arterial occlusive disease (PAOD) and dry-form of age-related macular degeneration (AMD) have been compared with the documented therapeutic results achieved with ozonated autohemotherapy (O-AHT). On the other hand, the clinical data of O-AHT on stroke remain indicative. As the cost of O-AHT is almost irrelevant, its application in all public hospitals, especially those of poor Countries, would allow two advantages: the first is for the patient, who will improve her/his conditions, and the second is for Health Authorities burdened with increasing costs. The aim of this paper is to report to clinical scientists that O-AHT is a scientific-based therapeutic approach without side effects. The integration of O-AHT with effective approved drugs is likely to yield the best clinical results in several chronic inflammatory diseases.en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofCARDIOVASCULAR & HAEMATOLOGICAL DISORDERS - DRUG TARGETSen_US
dc.titleValidity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseasesen_US
dc.typeArticleen_US
dc.identifier.doi10.2174/1871529X1502151209114642en_US
dc.identifier.scopus2-s2.0-84951201565en_US
dc.relation.volume15en_US
dc.relation.issue2en_US
dc.description.firstpage127en_US
dc.description.lastpage138en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0002-7574-4456-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.